Emergent BioSolutions to expand Mass. manufacturing work

Emergent BioSolutions Inc. plans to invest $75 million to expand its contract development and manufacturing organization's work and physical footprint in a moment of tremendous growth for the Maryland company.The Gaithersburg, Md., biotech has acquired property next to its Canton, Mass., manufacturing site to grow the campus where it will make drug material for its smallpox vaccine and other programs. Emergent (NYSE: EBS) expects to have drug-substance development and manufacturing services runn